Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

KKalaris Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
K

Kalaris Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Aug 27, 2026Vandekop Amy O'LearyVP, Corporate Controller10,000Stock Option (Right to Buy)—Grant / award
Aug 1, 2026KEATING LAURIEDirector18,000Stock Option (Right to Buy)—Grant / award
Jul 20, 2026Bayko Liisa AnnChief Financial Officer220,000Stock Option (Right to Buy)—Grant / award
Jun 3, 2026PATTERSON LEONE DDirector9,000Stock Option (Right to Buy)—Grant / award
Jun 3, 2026ADAMIS ANTHONY PDirector9,000Stock Option (Right to Buy)—Grant / award
Jun 3, 2026Dybbs MichaelDirector9,000Stock Option (Right to Buy)—Grant / award
Jun 3, 2026AKKARAJU SRINIVASDirector9,000Stock Option (Right to Buy)—Grant / award
Jun 3, 2026Hallal DavidDirector9,000Stock Option (Right to Buy)—Grant / award
Jun 3, 2026Ferrara NapoleoneDirector9,000Stock Option (Right to Buy)—Grant / award
Jun 3, 2026Jovan-Embiricos MoranaDirector9,000Stock Option (Right to Buy)—Grant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions